Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PFE | Common Stock | Options Exercise | $1.72M | +57K | +570.61% | $30.17 | 67K | Feb 22, 2023 | Direct | F1 |
transaction | PFE | Common Stock | Tax liability | -$341K | -8.04K | -12% | $42.38 | 59K | Feb 22, 2023 | Direct | F2 |
transaction | PFE | Common Stock | Tax liability | -$1.52M | -34.7K | -58.86% | $43.70 | 24.3K | Feb 22, 2023 | Direct | F3, F4 |
holding | PFE | Common Stock | 28.9K | Feb 22, 2023 | By Rule 16b-3 Plan | ||||||
holding | PFE | Common Stock | 8.53K | Feb 22, 2023 | By Spouse | F5 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PFE | Stock Appreciation Rights | Options Exercise | $0 | -57K | -100% | $0.00* | 0 | Feb 22, 2023 | Common Stock | 57K | $30.17 | Direct | |
transaction | PFE | Stock Appreciation Rights | Award | $0 | +103K | $0.00 | 103K | Feb 23, 2023 | Common Stock | 103K | $42.30 | Direct | F6 | |
transaction | PFE | Stock Appreciation Rights | Award | $0 | +89.9K | $0.00 | 89.9K | Feb 23, 2023 | Common Stock | 89.9K | $42.30 | Direct | F7 |
Id | Content |
---|---|
F1 | The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). |
F2 | The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. |
F3 | The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). |
F4 | Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. |
F5 | The reporting person disclaims beneficial ownership of the shares held by spouse. |
F6 | The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. |
F7 | The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. |